US Patent Issued to SORRISO PHARMACEUTICALS on Feb. 24 for "IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides" (British Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,552, issued on Feb. 24, was assigned to SORRISO PHARMACEUTICALS INC. (San Diego).

"IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides" was invented by Scott Crowe (Cambridge, Great Britain), Marion Cubitt (Cambridge, Great Britain), Tim Carlton (Cambridge, Great Britain), Luana Maggiore (Cambridge, Great Britain), Lurdes Duarte (Cambridge, Great Britain), Kevin Roberts (Cambridge, Great Britain) and Mike West (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided inter alia a polypeptide comprising an immunoglobulin chain variable domain which binds to IL-23, wherein the immunoglobulin chain variable...